Olink

Olink®
Part of Thermo Fisher Scientific

Scientific publications

Discover the latest research using Olink’s panels for protein biomarker discovery through our comprehensive list of publications. Easily find relevant studies by filtering them or using the free-text search.  Access abstracts, PubMed entries, and full-text papers directly through the links provided.

Filter

Filters

Publication
Disease Area
Application Area
Sample Type
Products

Nature, 2025

A neoantigen vaccine generates antitumour immunity in renal cell carcinoma

Braun D., Moranzoni G., Chea V. et al.

Cell Death Discovery, 2025

Pan-caspase inhibitors induce secretion of HIV-1 latency reversal agent lymphotoxin-alpha from cytokine-primed NK cells

Hajikhezri Z., Zygouras I., Sönnerborg A. et al.

Scientific Reports, 2025

Untargeted metabolomic and proteomic analysis implicates SIRT2 as a novel therapeutic target for diabetic nephropathy

Zhang R., Chang R., Wang H. et al.

Journal of Proteome Research, 2025

Serum Immune-Response Protein Biomarkers Based on Olink Technology for Diagnosis of Ischemic Stroke

Wang H., Zhao T., Zeng J. et al.

Journal of Ethnopharmacology, 2025

Lianhua Qingke Tablet in severe pneumonia: Clinical efficacy and immunoregulatory mechanisms

Jin P., Qi H., Zhao J. et al.

Journal of Translational Medicine, 2025

Multi-omics dissection of metabolic dysregulation associated with immune recovery in people living with HIV-1

Wan L., Lam S., Huang H. et al.

Clinical Cancer Research, 2025

Corticosteroid-Dependent Association between Prognostic Peripheral Blood Cell-Free DNA Levels and Neutrophil-Mediated NETosis in Patients with Glioblastoma

Till J., Seewald N., Yazdani Z. et al.

Molecular Neurobiology, 2025

Prospective Investigation Unravels Plasma Proteomic Links to Dementia

Li J., Li J., Chen S. et al.

Rheumatology, 2025

Plasma proteomics for risk prediction and identification of novel drug targets in systemic lupus erythematosus

Yang S., Zhang Y., Ye Z. et al.

Nature Medicine, 2025

Plasma proteomic evidence for increased β-amyloid pathology after SARS-CoV-2 infection

Duff E., Zetterberg H., Heslegrave A. et al.

Frontiers in Oncology, 2025

Enhancing glioblastoma therapy: unveiling synergistic anticancer effects of Onalespib - radiotherapy combination therapy

Uffenorde J., Hariri M., Papalanis E. et al.

Science Translational Medicine, 2025

Prior vaccination prevents overactivation of innate immune responses during COVID-19 breakthrough infection

Chan L., Pinedo K., Stabile M. et al.

Nature Communications, 2025

Increased plasma DOPA decarboxylase levels in Lewy body disorders are driven by dopaminergic treatment

Bolsewig K., Willemse E., Sánchez-Juan P. et al.

Journal of Inflammation Research, 2025

CLEC11A-Driven Molecular Mechanisms in Intervertebral Disc Degeneration: A Comprehensive Multi-Omics Study

Jiang N., Wang Q., Hu Z. et al.

Scientific Reports, 2025

Increased FGF-19 levels following explantation in women with breast implant illness

Azahaf S., Spit K., de Blok C. et al.

Heliyon, 2025

Identification of blood plasma protein ratios for distinguishing Alzheimer's disease from healthy controls using machine learning

Safi A., Giunti E., Melikechi O. et al.

Atherosclerosis, 2025

Identifying novel drug targets for calcific aortic valve disease through Mendelian randomization

Xu D., Lu J., Yang Y. et al.

Current Issues in Molecular Biology, 2025

The Role of Cytokines and Chemokines as Biomarkers of Disease Activity in Idiopathic Nephrotic Syndrome in Children

Kopač M., Jerin A., Petrera A. et al.

International Journal of Molecular Sciences, 2025

Comparative Assessment of Acute Pulmonary Effects Induced by Heat-Not-Burn Tobacco Aerosol Inhalation in a Murine Model

Kim B., Yang W., Seong Y. et al.

Frontiers in Immunology, 2025

Proteomics profiling of inflammatory responses to elexacaftor/tezacaftor/ivacaftor in cystic fibrosis

Ozuna H., Bojja D., Partida-Sanchez S. et al.

4586 publications